Acasti Pharma (ACST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ACST | SLGL | MGX | ||
| Company | Acasti Pharma | Sol-Gel Technologies Ltd | Metagenomi Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.38 | 80.13 | 1.3200 | ||
| High | 3.45 | 80.13 | 1.3300 | ||
| Low | 3.20 | 65.07 | 1.2500 | ||
| Latest | 3.37 | 68.54 | 1.2650 | ||
| Change | -0.03 | -10.66 | -0.0550 | ||
| % Change | -0.88% | -13.46% | -4.17% | ||
| Volume | 27,800 | 53,700 | 324,000 | ||
| 20-Day Average Volume | 34,930 | 37,265 | 269,655 | ||
| Previous Close | 3.40 | 79.20 | 1.3200 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 3.24 | 81.04 | 1.4833 | ||
| 20-Day Raw Stochastic | 72.29% | 18.36% | 2.61% | ||
| 20-Day Relative Strength | 58.39 | 45.87 | 37.89 | ||
| Weighted Alpha | +24.36 | +463.00 | -32.04 | ||
| Today's Opinion | 40% Buy | 56% Buy | 100% Sell | ||
| Previous Opinion | 40% Buy | 72% Buy | 100% Sell | ||
| Last Month's Opinion | 8% Sell | 100% Buy | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.20% since 10/18/24 | +3.53% since 03/23/26 | -11.54% since 03/23/26 | ||
| Low | 3.12 on 10/21/24 | 65.07 on 03/30/26 | 1.2500 on 03/30/26 | ||
| High | 3.60 on 10/23/24 | 93.53 on 03/24/26 | 1.4500 on 03/25/26 | ||
| 1-Month | |||||
| %Chg | +10.13% since 09/25/24 | -25.24% since 02/27/26 | -16.78% since 02/27/26 | ||
| Low | 2.77 on 10/01/24 | 61.92 on 03/23/26 | 1.2500 on 03/30/26 | ||
| High | 3.60 on 10/23/24 | 97.97 on 03/03/26 | 1.8250 on 03/10/26 | ||
| 3-Month | |||||
| %Chg | +19.08% since 07/25/24 | +63.78% since 12/26/25 | -25.59% since 12/26/25 | ||
| Low | 2.13 on 09/12/24 | 40.10 on 12/29/25 | 1.2500 on 03/30/26 | ||
| High | 3.60 on 10/23/24 | 97.97 on 03/03/26 | 1.8600 on 01/08/26 | ||
| 6-Month | |||||
| %Chg | +15.08% since 04/25/24 | +136.43% since 09/26/25 | -44.76% since 09/26/25 | ||
| Low | 2.13 on 09/12/24 | 27.00 on 10/02/25 | 1.2500 on 03/30/26 | ||
| High | 3.60 on 10/23/24 | 97.97 on 03/03/26 | 3.9500 on 10/16/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 31,676 | 222,544 | 49,660 | ||
| Shares Outstanding, K | 9,399 | 2,810 | 37,621 | ||
| Annual Sales | 0 | 19,390,000 | 25,210,000 | ||
| Annual Net Income | -12,850,000 | -6,130,000 | -87,870,000 | ||
| Last Quarter Sales | 0 | 700,000 | 3,910,000 | ||
| Last Quarter Net Income | -2,620,000 | -2,990,000 | -22,530,000 | ||
| 60-Month Beta | 1.52 | 1.30 | 0.45 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.24 on 08/09/24 | -1.07 on 03/19/26 | -0.60 on 03/05/26 | ||
| Latest Earnings Date | 11/11/24 | 05/22/26 | 05/12/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||